106 related articles for article (PubMed ID: 6398699)
1. Is ribonucleotide reductase in Ehrlich ascites mammary tumour cells the target of a growth inhibitor purified from bovine mammary gland?
Langen P; Lehmann W; Graetz H; Böhmer FD; Grosse R
Biomed Biochim Acta; 1984; 43(12):1377-83. PubMed ID: 6398699
[TBL] [Abstract][Full Text] [Related]
2. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro.
Lehmann W; Graetz H; Widmayer R; Langen P
Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265
[TBL] [Abstract][Full Text] [Related]
3. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
[TBL] [Abstract][Full Text] [Related]
4. Purification of a growth inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland.
Böhmer FD; Lehmann W; Schmidt HE; Langen P; Grosse R
Exp Cell Res; 1984 Feb; 150(2):466-76. PubMed ID: 6363109
[TBL] [Abstract][Full Text] [Related]
5. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI).
Lehmann W; Widmaier R; Langen P
Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246
[TBL] [Abstract][Full Text] [Related]
6. Purification of a chalone-like inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland.
Lehmann W; Samtleben R; Graetz H; Langen P
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):101-7. PubMed ID: 6221930
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine (NSC 118994) and inosinic acid.
Cory JG; Mansell MM; Whitford TW
Cancer Res; 1976 Sep; 36(9 pt.1):3166-70. PubMed ID: 987850
[TBL] [Abstract][Full Text] [Related]
8. Uridine diphosphate reductase of Ehrlich ascites tumor is insensitive to hydroxyurea.
Murayama J; Morita T; Fukui N; Moriyama Y; Fujimura S
Biochem Biophys Res Commun; 1985 Feb; 126(3):1104-8. PubMed ID: 3884001
[TBL] [Abstract][Full Text] [Related]
9. Progressive formation of DNA lesions in cultured Ehrlich ascites tumor cells treated with hydroxyurea.
Li JC; Kaminskas E
Cancer Res; 1987 Jun; 47(11):2755-8. PubMed ID: 3552205
[TBL] [Abstract][Full Text] [Related]
10. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
11. Characterization of membrane-associated growth inhibitor activity for Ehrlich ascites mammary carcinoma cells.
Herrmann I; Grosse R
Biomed Biochim Acta; 1986; 45(4):447-57. PubMed ID: 3010958
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of transforming growth factor activity in mammary epithelial tissues.
Eckert K; Lübbe L; Schön R; Grosse R
Biochem Int; 1985 Oct; 11(4):441-51. PubMed ID: 3878713
[TBL] [Abstract][Full Text] [Related]
13. Enantioselectivity of ribonucleotide reductase: a first study using stereoisomers of pyrimidine 2'-azido-2'-deoxynucleosides.
Roy B; Verri A; Lossani A; Spadari S; Focher F; Aubertin AM; Gosselin G; Mathé C; Périgaud C
Biochem Pharmacol; 2004 Aug; 68(4):711-8. PubMed ID: 15276078
[TBL] [Abstract][Full Text] [Related]
14. Aspects of chalone action.
Lehmann W; Graetz H; Schunck H; Schütt M; Langen P
Acta Histochem Suppl; 1983; 27():63-71. PubMed ID: 6223337
[TBL] [Abstract][Full Text] [Related]
15. Deoxycytidine, insulin and epidermal growth factor overcome the effect of two natural inhibitors of the haemopoietic system.
Schunk H; Schütt M; Langen P; Lord B; Laerum OD; Paukovits WR
APMIS Suppl; 1988; 2():120-9. PubMed ID: 3052515
[TBL] [Abstract][Full Text] [Related]
16. IGF-I, EGF, and sex steroids regulate autophagy in bovine mammary epithelial cells via the mTOR pathway.
Sobolewska A; Gajewska M; Zarzyńska J; Gajkowska B; Motyl T
Eur J Cell Biol; 2009 Feb; 88(2):117-30. PubMed ID: 19013662
[TBL] [Abstract][Full Text] [Related]
17. Homogeneous uridine kinase from Ehrlich ascites tumor: substrate specificity and inhibition by bisubstrate analogs.
Cheng N; Payne RC; Kemp WE; Traut TW
Mol Pharmacol; 1986 Aug; 30(2):159-63. PubMed ID: 3016499
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside requirements for the in vitro growth of bovine aortic endothelial cells.
Fenselau A; Kaiser D; Wallis K
J Cell Physiol; 1981 Sep; 108(3):375-84. PubMed ID: 7287826
[TBL] [Abstract][Full Text] [Related]
19. Biological activity and phosphorylation of 2'-azido-2'-deoxyuridine and 2'-azido-2'-deoxycytidine.
Kang SH; Cho MJ
Nucleosides Nucleotides; 1998 Jun; 17(6):1077-88. PubMed ID: 9708323
[TBL] [Abstract][Full Text] [Related]
20. Effects of adenosine and epidermal growth factor on the growth of mouse mammary epithelial cells.
Yuh IS; Jang BB; Hong BJ
Cell Biol Int; 1998; 22(2):131-5. PubMed ID: 9878100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
